Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test ...

More than 17,000 individuals with cancer died from their malignancy within a year of their diagnosis during the COVID-19 pandemic than expected based on previous trends.An evaluation of 1-year ...

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide ...

HOUSTON, TX / ACCESS Newswire / March 4, 2026 / BrYet US, Inc. ("BrYet") - a biotechnology innovator focused on ...

Fans says here’s a massive and precious IRL community around one of TV’s longest running reality shows. And it's younger and gayer than you think.

It’s still not clear what’s driving young-onset colorectal cancers. Suspected risk factors run the gamut from early ...

Namodenoson is a highly selective A3 adenosine receptor (A3AR) agonist, which has shown a compelling safety profile and demonstrated anti-tumor activity in preclinical pancreatic cancer models. The ...

David Lyon, now 31, was diagnosed with stage 4 colon cancer at 26. For March's Colorectal Cancer Awareness Month, he's urging ...

Next-generation, non-invasive diagnostic platform has potential applications in solid tumor types beyond liver cancerLicensing deal reflects ...

Nick Leeson was diagnosed with colon cancer in prison and had surgery and treatment. He says self-pity was pointless despite his grim circumstances.

Survival rates for people with cholangiocarcinoma, a silent but deadly form of cancer originating in the bile ducts, are dismal and a new approach is needed, argues a panel of leading experts ...